AdVance™ XP male sling implantation for stress urinary incontinence after orthotopic ileal neobladder reconstruction
Abstract
Stress urinary incontinence (UI) after radical cystectomy with orthotopic ileal neobladder reconstruction remains a challenging condition in men, with very limited evidence regarding surgical management. Specifically, experience with male sling implantation in this setting is limited to a few published cases. We report a 63-year-old male with mixed UI using three pads per day and ICIQ-SF 15, unresponsive to conservative therapy. An AdVance™ XP sling was implanted via transobturator approach. At six months, pad use decreased to 1–2 per day and ICIQ-SF improved to 7, with complete resolution of the stress component and persistence of urgency UI alone. Post-void residual volumes remained low, and no complications were observed. Male sling implantation may represent a less invasive alternative to the artificial urinary sphincter in carefully selected patients, although careful tensioning is essential to avoid urinary retention. This case adds to the scarce published evidence supporting the feasibility of AdVance™ XP sling implantation in men with orthotopic ileal neobladders, although further studies are needed to confirm its long-term safety and effectiveness.
##plugins.themes.bootstrap3.article.details##
stress urinary incontinence, male urethral sling, orthotopic ileal neobladder, radical cystectomy, artificial urinary sphincter, urinary diversion
2. Bahlburg H, Schuster F, Tully KH, et al. Prospective evaluation of functional outcomes in 395 patients with an ileal neobladder 1 year after radical cystectomy. World J Urol. 2023 Sep;41(9):2367-2374. doi: 10.1007/s00345-023-04520-x. Epub 2023 Jul 15. PMID: 37452866; PMCID: PMC10465372.
3. Hautmann RE. Management of male voiding dysfunction after radical cystectomy and neobladder reconstruction. Curr Bladder Dysfunct Rep. 2012; (7):286–293. https://doi.org/10.1007/s11884-012-0151-x.
4. European Association of Urology. EAU guidelines on management of non-neurogenic male LUTS, including male urinary incontinence. Arnhem, The Netherlands: EAU Guidelines Office; 2026. [Available from: https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts at 8/21/2026].
5. Park JJ, Hong Y, Kwon A, Shim SR, Kim JH. Efficacy of surgical treatment for post-prostatectomy urinary incontinence: a systematic review and network meta-analysis. Int J Surg. 2023 Mar 1;109(3):401-411. doi: 10.1097/JS9.0000000000000170. PMID: 36912884; PMCID: PMC10389629.
6. Hoy NY, Cohn JA, Kowalik CG, Kaufman MR, Stuart Reynolds W, Dmochowski RR. Management of Voiding Dysfunction After Female Neobladder Creation. Curr Urol Rep. 2017 May;18(5):33. doi: 10.1007/s11934-017-0682-y. PMID: 28283915.
7. Bauer RM, Mayer ME, May F, et al. Complications of the AdVance transobturator male sling in the treatment of male stress urinary incontinence. Urology. 2010 Jun;75(6):1494-8. doi: 10.1016/j.urology.2009.12.012. PMID: 20156654.
8. Minowada S, Sasaki Y, Kano M, Okano Y. Sling operation for male urinary incontinence after ileal neobladder reconstruction: a case report. Int J Urol. 1995 May;2(2):132-3; discussion 134. doi: 10.1111/j.1442-2042.1995.tb00440.x. PMID: 7553287.
9. Simma-Chiang V, Ginsberg DA, Teruya KK, Boyd SD. Outcomes of artificial urinary sphincter placement in men after radical cystectomy and orthotopic urinary diversions for the treatment of stress urinary incontinence: the University of Southern California experience. Urology. 2012 Jun;79(6):1397-401. doi: 10.1016/j.urology.2012.02.006. PMID: 22449453.
10. Vainrib M, Simma-Chiang V, Boyd SD, Ginsberg DA. Potential risk factors and outcomes of artificial urinary sphincter placement after radical cystectomy and orthotopic neobladder urinary diversion. Neurourol Urodyn. 2013 Sep;32(7):1010-3. doi: 10.1002/nau.22345. Epub 2013 Apr 17. PMID: 23595916.
11. Loh-Doyle JC, Ashrafi A, Nazemi A, et al. Dual Prosthetic Implantation After Radical Cystoprostatectomy and Neobladder: Outcomes of the Inflatable Penile Prosthesis and Artificial Urinary Sphincter in Bladder Cancer Survivors. Urology. 2019 May;127:127-132. doi: 10.1016/j.urology.2019.01.010. PMID: 30664894.
12. Kaufman MR, Wood HM, Terlecki R, et al. The Artificial Urinary Sphincter Clinical Outcomes Trial: Primary Results. J Urol. 2026 Feb;215(2):194-202. doi: 10.1097/JU.0000000000004796. PMID: 41042705; PMCID: PMC12794701.
13. Ducos V, Pelette R, Lescure V, et al. Long-term follow-up of AdVance™XP male sling for post-prostatectomy incontinence. Fr J Urol. 2025 Aug;35(6-7):102881. doi: 10.1016/j.fjurol.2025.102881. PMID: 40086598.
14. Asimakopoulos AD, Finazzi Agrò E, Piechaud T, Gakis G, Gaston R, Rosato E. Urodynamic parameters and continence outcomes in asymptomatic patients with ileal orthotopic neobladder: a systematic review and meta-analysis. Cancers (Basel). 2024;16(7):1253. doi:10.3390/cancers16071253.
15. Smith WJ, VanDyke ME, Venishetty N, Langford BT, Franzen BP, Morey AF. Surgical Management of Male Stress Incontinence: Techniques, Indications, and Pearls for Success. Res Rep Urol. 2023 Jun 21;15:217-232. doi: 10.2147/RRU.S395359. PMID: 37366389; PMCID: PMC10290851.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.
https://orcid.org/0009-0007-7168-5499